KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Equity Average (2016 - 2025)

Historic Equity Average for Amgen (AMGN) over the last 16 years, with Q3 2025 value amounting to $8.5 billion.

  • Amgen's Equity Average rose 2672.47% to $8.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 billion, marking a year-over-year increase of 2672.47%. This contributed to the annual value of $6.1 billion for FY2024, which is 2239.97% up from last year.
  • Per Amgen's latest filing, its Equity Average stood at $8.5 billion for Q3 2025, which was up 2672.47% from $6.8 billion recorded in Q2 2025.
  • Over the past 5 years, Amgen's Equity Average peaked at $9.4 billion during Q1 2021, and registered a low of $1.7 billion during Q2 2022.
  • Moreover, its 5-year median value for Equity Average was $6.7 billion (2024), whereas its average is $6.1 billion.
  • Per our database at Business Quant, Amgen's Equity Average crashed by 8103.07% in 2022 and then skyrocketed by 26368.82% in 2023.
  • Over the past 5 years, Amgen's Equity Average (Quarter) stood at $7.5 billion in 2021, then crashed by 50.97% to $3.7 billion in 2022, then surged by 89.88% to $6.9 billion in 2023, then fell by 3.49% to $6.7 billion in 2024, then grew by 27.18% to $8.5 billion in 2025.
  • Its Equity Average was $8.5 billion in Q3 2025, compared to $6.8 billion in Q2 2025 and $6.0 billion in Q1 2025.